183 related articles for article (PubMed ID: 17294383)
21. Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management.
Laibovitz RA; VanDenburgh AM; Felix C; David R; Batoosingh A; Rosenthal A; Cheetham J
Arch Ophthalmol; 2001 Jul; 119(7):994-1000. PubMed ID: 11448321
[TBL] [Abstract][Full Text] [Related]
22. A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.
Nixon DR
J Ocul Pharmacol Ther; 2013 Dec; 29(10):876-81. PubMed ID: 24070367
[TBL] [Abstract][Full Text] [Related]
23. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.
Eisenberg DL; Toris CB; Camras CB
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S105-15. PubMed ID: 12204706
[TBL] [Abstract][Full Text] [Related]
24. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
[TBL] [Abstract][Full Text] [Related]
25. A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.
Whitcup SM; Cantor LB; VanDenburgh AM; Chen K
Br J Ophthalmol; 2003 Jan; 87(1):57-62. PubMed ID: 12488264
[TBL] [Abstract][Full Text] [Related]
26. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension.
Higginbotham EJ; Schuman JS; Goldberg I; Gross RL; VanDenburgh AM; Chen K; Whitcup SM;
Arch Ophthalmol; 2002 Oct; 120(10):1286-93. PubMed ID: 12365906
[TBL] [Abstract][Full Text] [Related]
27. Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study.
Feuerhake C; Buchholz P; Kimmich F
Curr Med Res Opin; 2009 Apr; 25(4):1037-43. PubMed ID: 19290780
[TBL] [Abstract][Full Text] [Related]
28. Does the fixed combination of bimatoprost/timolol really produce a better benefit/risk balance than the fixed combination of latanoprost/timolol?
Soto J; Diaz S
Eur J Ophthalmol; 2010; 20(1):246-7; author reply 247-8. PubMed ID: 20047180
[No Abstract] [Full Text] [Related]
29. Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.
Centofanti M; Oddone F; Gandolfi S; Hommer A; Boehm A; Tanga L; Sangermani C; Sportelli V; Haustein M; Manni G; Rossetti L
Am J Ophthalmol; 2010 Oct; 150(4):575-80. PubMed ID: 20688314
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of the fixed combinations of bimatoprost or latanoprost plus timolol in patients uncontrolled with prostaglandin monotherapy: a multicenter, randomized, investigator-masked, clinical study.
Centofanti M; Oddone F; Vetrugno M; Manni G; Fogagnolo P; Tanga L; Ferreri P; Rossetti L
Eur J Ophthalmol; 2009; 19(1):66-71. PubMed ID: 19123151
[TBL] [Abstract][Full Text] [Related]
31. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
Parrish RK; Palmberg P; Sheu WP;
Am J Ophthalmol; 2003 May; 135(5):688-703. PubMed ID: 12719078
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
33. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
Topouzis F; Melamed S; Danesh-Meyer H; Wells AP; Kozobolis V; Wieland H; Andrew R; Wells D
Eur J Ophthalmol; 2007; 17(2):183-90. PubMed ID: 17415690
[TBL] [Abstract][Full Text] [Related]
34. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
Cantor LB; WuDunn D; Cortes A; Hoop J; Knotts S
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S12-8. PubMed ID: 15016557
[TBL] [Abstract][Full Text] [Related]
35. Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%.
Scherzer ML; Liehneova I; Negrete FJ; Schnober D
Adv Ther; 2011 Aug; 28(8):661-70. PubMed ID: 21773673
[TBL] [Abstract][Full Text] [Related]
36. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.
Coleman AL; Lerner F; Bernstein P; Whitcup SM
Ophthalmology; 2003 Dec; 110(12):2362-8. PubMed ID: 14644719
[TBL] [Abstract][Full Text] [Related]
37. Modern alchemy: fixed combinations of glaucoma drugs.
Katz LJ
Am J Ophthalmol; 2005 Jul; 140(1):125-6. PubMed ID: 16038653
[No Abstract] [Full Text] [Related]
38. A 6-month assessment of bimatoprost 0.03% vs timolol maleate 0.5%: hypotensive efficacy, macular thickness and flare in ocular-hypertensive and glaucoma patients.
Martin E; Martinez-de-la-Casa JM; Garcia-Feijoo J; Troyano J; Larrosa JM; Garcia-Sanchez J
Eye (Lond); 2007 Feb; 21(2):164-8. PubMed ID: 16254590
[TBL] [Abstract][Full Text] [Related]
39. Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Belfort R; Paula JS; Lopes Silva MJ; Della Paolera M; Kim T; Chen MY; Goodkin ML
Clin Ther; 2020 Feb; 42(2):263-275. PubMed ID: 32089329
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.
Schuman JS; Katz GJ; Lewis RA; Henry JC; Mallick S; Wells DT; Sullivan EK; Landry TA; Bergamini MV; Robertson SM
Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
